Additional file 5: of Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study

Table presenting “Multivariate analysis of patient baseline characteristics for the effect of interaction with axitinib titration on OS.” (PDF 105 kb)